Patents by Inventor Jennifer Watkins

Jennifer Watkins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230265189
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Application
    Filed: March 30, 2023
    Publication date: August 24, 2023
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon, Sri Sahitya Vadde
  • Patent number: 11639385
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Grant
    Filed: December 27, 2019
    Date of Patent: May 2, 2023
    Assignee: PD-1 Acquisition Group, LLC
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon, Sri Sahitya Vadde
  • Publication number: 20230045791
    Abstract: The invention provides monoclonal antibodies and antigen-binding fragments thereof specific for TNFR2, and methods of using the same to treat cancer or autoimmune disorder, including combination therapy with antagonists of the PD-1/PD-L1 immune checkpoint.
    Type: Application
    Filed: January 5, 2021
    Publication date: February 16, 2023
    Inventors: Shuo Wei, Liang Schweizer, Francisco Adrian, Nicola Arturo Aldo Beltraminelli, Pascaline Mary, Matthieu Delince, Qian Zhang, Jennifer Watkins
  • Publication number: 20200190187
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Application
    Filed: December 27, 2019
    Publication date: June 18, 2020
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon, Sri Sahitya Vadde
  • Publication number: 20200109195
    Abstract: The present disclosure provides immunotherapeutic compositions and methods for enhancing an immune response and for treating cancer or inflammatory conditions mediated by autoreactive B cells in a subject. In some aspects, multispecific antigen-binding constructs are provided that recognize at least one tumor antigen or B-lineage cell antigen and NKp30 and/or another activating NK receptor. In some aspects, multispecific antigen-binding constructs are provided that recognize at least two tumor antigens or two antigens expressed by B-lineage cells, NKp30, and another activating NK receptor. The multispecific antigen-binding constructs and methods disclosed herein can be used for the treatment of cancer, even a cancer characterized by a CD16 deficient microenvironment and/or characterized by target cells (e.g., cancer cells) having a low level of expression of the tumor antigen.
    Type: Application
    Filed: May 21, 2019
    Publication date: April 9, 2020
    Applicant: COMPASS THERAPEUTICS LLC
    Inventors: Jennifer Watkins, Michael March Schmidt, Monia Draghi, Amanda Frank Oliphant, Sara Marie Halmos, Thomas Joseph Schuetz, Jason Michael Lajoie, Allison Nelson
  • Publication number: 20200079867
    Abstract: The present disclosure provides immunotherapeutic compositions and methods for enhancing an immune response and for treating cancer or inflammatory conditions mediated by autoreactive B cells in a subject. In some aspects, multispecific antigen-binding constructs are provided that recognize at least one tumor antigen or B-lineage cell antigen and NKp30 and/or another activating NK receptor. In some aspects, multispecific antigen-binding constructs are provided that recognize at least two tumor antigens or two antigens expressed by B-lineage cells, NKp30, and another activating NK receptor. The multispecific antigen-binding constructs and methods disclosed herein can be used for the treatment of cancer, even a cancer characterized by a CD16 deficient microenvironment and/or characterized by target cells (e.g., cancer cells) having a low level of expression of the tumor antigen.
    Type: Application
    Filed: September 26, 2019
    Publication date: March 12, 2020
    Applicant: COMPASS THERAPEUTICS LLC
    Inventors: Jennifer Watkins, Michael March Schmidt, Monia Draghi, Amanda Frank Oliphant, Sara Marie Halmos, Thomas Joseph Schuetz, Jason Michael Lajoie, Allison Nelson
  • Patent number: 10544217
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Grant
    Filed: May 11, 2016
    Date of Patent: January 28, 2020
    Assignee: PD-1 Acquisition Group, LLC
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon, Sri Sahitya Vadde
  • Patent number: 10512162
    Abstract: A device may include a flexible substrate. The device may further include a flexible integrated circuit within the flexible substrate, the integrated circuit having at least one input electrode positioned on a surface of the flexible substrate. The device may also include an aerosol jet printed conductive ink layer disposed on the surface of the flexible substrate, the aerosol-jet printed conductive ink layer having a pattern that includes a first set of fingers interdigitated with a second set of fingers, the aerosol jet printed conductive ink layer in contact with the at least one input electrode.
    Type: Grant
    Filed: May 3, 2018
    Date of Patent: December 17, 2019
    Assignee: BOISE STATE UNIVERSITY
    Inventors: David Estrada, Jennifer Watkins, Aline Elquist, Carter Warren, Preston Riggs, Kiyo Fujimoto, Harish Subbaraman
  • Patent number: 10239942
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Grant
    Filed: December 19, 2015
    Date of Patent: March 26, 2019
    Assignee: PD-1 Acquisition Group, LLC
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon, Sri Sahitya Vadde
  • Publication number: 20180324948
    Abstract: A device may include a flexible substrate. The device may further include a flexible integrated circuit within the flexible substrate, the integrated circuit having at least one input electrode positioned on a surface of the flexible substrate. The device may also include an aerosol jet printed conductive ink layer disposed on the surface of the flexible substrate, the aerosol-jet printed conductive ink layer having a pattern that includes a first set of fingers interdigitated with a second set of fingers, the aerosol jet printed conductive ink layer in contact with the at least one input electrode.
    Type: Application
    Filed: May 3, 2018
    Publication date: November 8, 2018
    Inventors: David Estrada, Jennifer Watkins, Aline Elquist, Carter Warren, Preston Riggs, Kiyo Fujimoto, Harish Subbaraman
  • Patent number: 9740990
    Abstract: This invention is a method and system for reserving and controlling access to products and services at a remote location via a communications network. In one or more embodiment, a user uses a client computer to select desired products and services. The system returns a price offer for the packaged products and services. Upon acceptance of the price offer, the selection of products and services is forwarded to an operations center for the building of an event regarding the redemption of the products and services. The system allocates a time frame for the redemption of each of the products and services as well as determining the order of redemption, based on polling a plurality of users desiring the same products and services in an event. The information generated by the operation center is then forwarded to a location for the redemption of the products and services.
    Type: Grant
    Filed: May 10, 2011
    Date of Patent: August 22, 2017
    Assignee: Starlight LLC
    Inventor: Jennifer Watkins
  • Publication number: 20160319019
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Application
    Filed: May 11, 2016
    Publication date: November 3, 2016
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon
  • Publication number: 20160251436
    Abstract: Antibodies that bind to programmed cell death protein 1 (PD-1), compositions comprising such antibodies, and methods of making and using such antibodies are disclosed.
    Type: Application
    Filed: December 19, 2015
    Publication date: September 1, 2016
    Inventors: Najmia Amirina, Hareesh Chamarthi, Maria Isabel Chiu, Daniel Doty, Bin Feng, Aleksander Jonca, Thomas McQuade, Anhco Nguyen, Sheila Ranganath, Hans Albert Felix Scheuplein, Vikki A. Spaulding, Lei Wang, Jennifer Watkins-Yoon
  • Publication number: 20110213630
    Abstract: This invention is a method and system for reserving and controlling access to products and services at a remote location via a communications network. In one or more embodiment, a user uses a client computer to select desired products and services. The system returns a price offer for the packaged products and services. Upon acceptance of the price offer, the selection of products and services is forwarded to an operations center for the building of an event regarding the redemption of the products and services. The system allocates a time frame for the redemption of each of the products and services as well as determining the order of redemption, based on polling a plurality of users desiring the same products and services in an event. The information generated by the operation center is then forwarded to a location for the redemption of the products and services.
    Type: Application
    Filed: May 10, 2011
    Publication date: September 1, 2011
    Inventor: Jennifer Watkins
  • Publication number: 20080040172
    Abstract: This invention is a method and system for reserving and controlling access to products and services at a remote location via a communications network. In one or more embodiment, a user uses a client computer to select desired products and services. The system returns a price offer for the packaged products and services. Upon acceptance of the price offer, the selection of products and services is forwarded to an operations center for the building of an event regarding the redemption of the products and services. The system allocates a time frame for the redemption of each of the products and services as well as determining the order of redemption, based on polling a plurality of users desiring the same products and services in an event. The information generated by the operation center is then forwarded to a location for the redemption of the products and services.
    Type: Application
    Filed: September 16, 2005
    Publication date: February 14, 2008
    Inventor: Jennifer Watkins